Global C-X-C Chemokine Receptor Type 4 Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 83232
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The C-X-C Chemokine Receptor Type 4 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global C-X-C Chemokine Receptor Type 4 size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global C-X-C Chemokine Receptor Type 4 market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

C-X-C Chemokine Receptor Type 4 market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

AM-3114

BL-8040

GMI-1359

HPH-112

Others

Market segment by Application, can be divided into

Liver Cancer

Myocardial Infarction

Renal Cell Carcinoma

Stroke

Others

Market segment by players, this report covers

AdAlta Pty Ltd.

Ambrx, Inc.

Anchor Therapeutics, Inc.

Biokine Therapeutics Ltd.

BioLineRx, Ltd.

Bristol-Myers Squibb Company

Eli Lilly and Company

Globavir Biosciences, Inc.

GlycoMimetics, Inc.

NeED Pharma s.r.l.

Pharis Biotec GmbH

Polyphor Ltd.

Sanofi

TaiGen Biotechnology Co., Ltd.

Upsher-Smith Laboratories, Inc.

X4 Pharmaceuticals, Inc.

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe C-X-C Chemokine Receptor Type 4 product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of C-X-C Chemokine Receptor Type 4, with revenue, gross margin and global market share of C-X-C Chemokine Receptor Type 4 from 2019 to 2021.

Chapter 3, the C-X-C Chemokine Receptor Type 4 competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and C-X-C Chemokine Receptor Type 4 market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe C-X-C Chemokine Receptor Type 4 research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of C-X-C Chemokine Receptor Type 4

1.2 Classification of C-X-C Chemokine Receptor Type 4 by Type

1.2.1 Overview: Global C-X-C Chemokine Receptor Type 4 Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Type in 2020

1.2.3 AM-3114

1.2.4 BL-8040

1.2.5 GMI-1359

1.2.6 HPH-112

1.2.7 Others

1.3 Global C-X-C Chemokine Receptor Type 4 Market by Application

1.3.1 Overview: Global C-X-C Chemokine Receptor Type 4 Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Liver Cancer

1.3.3 Myocardial Infarction

1.3.4 Renal Cell Carcinoma

1.3.5 Stroke

1.3.6 Others

1.4 Global C-X-C Chemokine Receptor Type 4 Market Size & Forecast

1.5 Global C-X-C Chemokine Receptor Type 4 Market Size and Forecast by Region

1.5.1 Global C-X-C Chemokine Receptor Type 4 Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global C-X-C Chemokine Receptor Type 4 Market Size by Region, (2016-2021)

1.5.3 North America C-X-C Chemokine Receptor Type 4 Market Size and Prospect (2016-2026)

1.5.4 Europe C-X-C Chemokine Receptor Type 4 Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size and Prospect (2016-2026)

1.5.6 South America C-X-C Chemokine Receptor Type 4 Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa C-X-C Chemokine Receptor Type 4 Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 C-X-C Chemokine Receptor Type 4 Market Drivers

1.6.2 C-X-C Chemokine Receptor Type 4 Market Restraints

1.6.3 C-X-C Chemokine Receptor Type 4 Trends Analysis

2 Company Profiles

2.1 AdAlta Pty Ltd.

2.1.1 AdAlta Pty Ltd. Details

2.1.2 AdAlta Pty Ltd. Major Business

2.1.3 AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Product and Solutions

2.1.4 AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 AdAlta Pty Ltd. Recent Developments and Future Plans

2.2 Ambrx, Inc.

2.2.1 Ambrx, Inc. Details

2.2.2 Ambrx, Inc. Major Business

2.2.3 Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Product and Solutions

2.2.4 Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Ambrx, Inc. Recent Developments and Future Plans

2.3 Anchor Therapeutics, Inc.

2.3.1 Anchor Therapeutics, Inc. Details

2.3.2 Anchor Therapeutics, Inc. Major Business

2.3.3 Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Product and Solutions

2.3.4 Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Anchor Therapeutics, Inc. Recent Developments and Future Plans

2.4 Biokine Therapeutics Ltd.

2.4.1 Biokine Therapeutics Ltd. Details

2.4.2 Biokine Therapeutics Ltd. Major Business

2.4.3 Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Product and Solutions

2.4.4 Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Biokine Therapeutics Ltd. Recent Developments and Future Plans

2.5 BioLineRx, Ltd.

2.5.1 BioLineRx, Ltd. Details

2.5.2 BioLineRx, Ltd. Major Business

2.5.3 BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Product and Solutions

2.5.4 BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 BioLineRx, Ltd. Recent Developments and Future Plans

2.6 Bristol-Myers Squibb Company

2.6.1 Bristol-Myers Squibb Company Details

2.6.2 Bristol-Myers Squibb Company Major Business

2.6.3 Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Product and Solutions

2.6.4 Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Bristol-Myers Squibb Company Recent Developments and Future Plans

2.7 Eli Lilly and Company

2.7.1 Eli Lilly and Company Details

2.7.2 Eli Lilly and Company Major Business

2.7.3 Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Product and Solutions

2.7.4 Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Eli Lilly and Company Recent Developments and Future Plans

2.8 Globavir Biosciences, Inc.

2.8.1 Globavir Biosciences, Inc. Details

2.8.2 Globavir Biosciences, Inc. Major Business

2.8.3 Globavir Biosciences, Inc. C-X-C Chemokine Receptor Type 4 Product and Solutions

2.8.4 Globavir Biosciences, Inc. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Globavir Biosciences, Inc. Recent Developments and Future Plans

2.9 GlycoMimetics, Inc.

2.9.1 GlycoMimetics, Inc. Details

2.9.2 GlycoMimetics, Inc. Major Business

2.9.3 GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Product and Solutions

2.9.4 GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 GlycoMimetics, Inc. Recent Developments and Future Plans

2.10 NeED Pharma s.r.l.

2.10.1 NeED Pharma s.r.l. Details

2.10.2 NeED Pharma s.r.l. Major Business

2.10.3 NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Product and Solutions

2.10.4 NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 NeED Pharma s.r.l. Recent Developments and Future Plans

2.11 Pharis Biotec GmbH

2.11.1 Pharis Biotec GmbH Details

2.11.2 Pharis Biotec GmbH Major Business

2.11.3 Pharis Biotec GmbH C-X-C Chemokine Receptor Type 4 Product and Solutions

2.11.4 Pharis Biotec GmbH C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Pharis Biotec GmbH Recent Developments and Future Plans

2.12 Polyphor Ltd.

2.12.1 Polyphor Ltd. Details

2.12.2 Polyphor Ltd. Major Business

2.12.3 Polyphor Ltd. C-X-C Chemokine Receptor Type 4 Product and Solutions

2.12.4 Polyphor Ltd. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Polyphor Ltd. Recent Developments and Future Plans

2.13 Sanofi

2.13.1 Sanofi Details

2.13.2 Sanofi Major Business

2.13.3 Sanofi C-X-C Chemokine Receptor Type 4 Product and Solutions

2.13.4 Sanofi C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Sanofi Recent Developments and Future Plans

2.14 TaiGen Biotechnology Co., Ltd.

2.14.1 TaiGen Biotechnology Co., Ltd. Details

2.14.2 TaiGen Biotechnology Co., Ltd. Major Business

2.14.3 TaiGen Biotechnology Co., Ltd. C-X-C Chemokine Receptor Type 4 Product and Solutions

2.14.4 TaiGen Biotechnology Co., Ltd. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 TaiGen Biotechnology Co., Ltd. Recent Developments and Future Plans

2.15 Upsher-Smith Laboratories, Inc.

2.15.1 Upsher-Smith Laboratories, Inc. Details

2.15.2 Upsher-Smith Laboratories, Inc. Major Business

2.15.3 Upsher-Smith Laboratories, Inc. C-X-C Chemokine Receptor Type 4 Product and Solutions

2.15.4 Upsher-Smith Laboratories, Inc. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Upsher-Smith Laboratories, Inc. Recent Developments and Future Plans

2.16 X4 Pharmaceuticals, Inc.

2.16.1 X4 Pharmaceuticals, Inc. Details

2.16.2 X4 Pharmaceuticals, Inc. Major Business

2.16.3 X4 Pharmaceuticals, Inc. C-X-C Chemokine Receptor Type 4 Product and Solutions

2.16.4 X4 Pharmaceuticals, Inc. C-X-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 X4 Pharmaceuticals, Inc. Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global C-X-C Chemokine Receptor Type 4 Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 C-X-C Chemokine Receptor Type 4 Players Market Share

3.2.2 Top 10 C-X-C Chemokine Receptor Type 4 Players Market Share

3.2.3 Market Competition Trend

3.3 C-X-C Chemokine Receptor Type 4 Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global C-X-C Chemokine Receptor Type 4 Revenue and Market Share by Type (2016-2021)

4.2 Global C-X-C Chemokine Receptor Type 4 Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Application (2016-2021)

5.2 C-X-C Chemokine Receptor Type 4 Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America C-X-C Chemokine Receptor Type 4 Revenue by Type (2016-2026)

6.2 North America C-X-C Chemokine Receptor Type 4 Revenue by Application (2016-2026)

6.3 North America C-X-C Chemokine Receptor Type 4 Market Size by Country

6.3.1 North America C-X-C Chemokine Receptor Type 4 Revenue by Country (2016-2026)

6.3.2 United States C-X-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)

6.3.3 Canada C-X-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)

6.3.4 Mexico C-X-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe C-X-C Chemokine Receptor Type 4 Revenue by Type (2016-2026)

7.2 Europe C-X-C Chemokine Receptor Type 4 Revenue by Application (2016-2026)

7.3 Europe C-X-C Chemokine Receptor Type 4 Market Size by Country

7.3.1 Europe C-X-C Chemokine Receptor Type 4 Revenue by Country (2016-2026)

7.3.2 Germany C-X-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)

7.3.3 France C-X-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)

7.3.4 United Kingdom C-X-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)

7.3.5 Russia C-X-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)

7.3.6 Italy C-X-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific C-X-C Chemokine Receptor Type 4 Revenue by Type (2016-2026)

8.2 Asia-Pacific C-X-C Chemokine Receptor Type 4 Revenue by Application (2016-2026)

8.3 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Region

8.3.1 Asia-Pacific C-X-C Chemokine Receptor Type 4 Revenue by Region (2016-2026)

8.3.2 China C-X-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)

8.3.3 Japan C-X-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)

8.3.4 South Korea C-X-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)

8.3.5 India C-X-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia C-X-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)

8.3.7 Australia C-X-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America C-X-C Chemokine Receptor Type 4 Revenue by Type (2016-2026)

9.2 South America C-X-C Chemokine Receptor Type 4 Revenue by Application (2016-2026)

9.3 South America C-X-C Chemokine Receptor Type 4 Market Size by Country

9.3.1 South America C-X-C Chemokine Receptor Type 4 Revenue by Country (2016-2026)

9.3.2 Brazil C-X-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)

9.3.3 Argentina C-X-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa C-X-C Chemokine Receptor Type 4 Revenue by Type (2016-2026)

10.2 Middle East & Africa C-X-C Chemokine Receptor Type 4 Revenue by Application (2016-2026)

10.3 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Country

10.3.1 Middle East & Africa C-X-C Chemokine Receptor Type 4 Revenue by Country (2016-2026)

10.3.2 Turkey C-X-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia C-X-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)

10.3.4 UAE C-X-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global C-X-C Chemokine Receptor Type 4 Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global C-X-C Chemokine Receptor Type 4 Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market C-X-C Chemokine Receptor Type 4 Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global C-X-C Chemokine Receptor Type 4 Revenue (USD Million) by Region (2016-2021)

Table 5. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Region (2021-2026)

Table 6. AdAlta Pty Ltd. Corporate Information, Head Office, and Major Competitors

Table 7. AdAlta Pty Ltd. Major Business

Table 8. AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Product and Solutions

Table 9. AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Ambrx, Inc. Corporate Information, Head Office, and Major Competitors

Table 11. Ambrx, Inc. Major Business

Table 12. Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Product and Solutions

Table 13. Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Anchor Therapeutics, Inc. Corporate Information, Head Office, and Major Competitors

Table 15. Anchor Therapeutics, Inc. Major Business

Table 16. Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Product and Solutions

Table 17. Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Biokine Therapeutics Ltd. Corporate Information, Head Office, and Major Competitors

Table 19. Biokine Therapeutics Ltd. Major Business

Table 20. Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Product and Solutions

Table 21. Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. BioLineRx, Ltd. Corporate Information, Head Office, and Major Competitors

Table 23. BioLineRx, Ltd. Major Business

Table 24. BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Product and Solutions

Table 25. BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Bristol-Myers Squibb Company Corporate Information, Head Office, and Major Competitors

Table 27. Bristol-Myers Squibb Company Major Business

Table 28. Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Product and Solutions

Table 29. Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors

Table 31. Eli Lilly and Company Major Business

Table 32. Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Product and Solutions

Table 33. Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Globavir Biosciences, Inc. Corporate Information, Head Office, and Major Competitors

Table 35. Globavir Biosciences, Inc. Major Business

Table 36. Globavir Biosciences, Inc. C-X-C Chemokine Receptor Type 4 Product and Solutions

Table 37. Globavir Biosciences, Inc. C-X-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. GlycoMimetics, Inc. Corporate Information, Head Office, and Major Competitors

Table 39. GlycoMimetics, Inc. Major Business

Table 40. GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Product and Solutions

Table 41. GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. NeED Pharma s.r.l. Corporate Information, Head Office, and Major Competitors

Table 43. NeED Pharma s.r.l. Major Business

Table 44. NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Product and Solutions

Table 45. NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Pharis Biotec GmbH Corporate Information, Head Office, and Major Competitors

Table 47. Pharis Biotec GmbH Major Business

Table 48. Pharis Biotec GmbH C-X-C Chemokine Receptor Type 4 Product and Solutions

Table 49. Pharis Biotec GmbH C-X-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Polyphor Ltd. Corporate Information, Head Office, and Major Competitors

Table 51. Polyphor Ltd. Major Business

Table 52. Polyphor Ltd. C-X-C Chemokine Receptor Type 4 Product and Solutions

Table 53. Polyphor Ltd. C-X-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Sanofi Corporate Information, Head Office, and Major Competitors

Table 55. Sanofi Major Business

Table 56. Sanofi C-X-C Chemokine Receptor Type 4 Product and Solutions

Table 57. Sanofi C-X-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. TaiGen Biotechnology Co., Ltd. Corporate Information, Head Office, and Major Competitors

Table 59. TaiGen Biotechnology Co., Ltd. Major Business

Table 60. TaiGen Biotechnology Co., Ltd. C-X-C Chemokine Receptor Type 4 Product and Solutions

Table 61. TaiGen Biotechnology Co., Ltd. C-X-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Upsher-Smith Laboratories, Inc. Corporate Information, Head Office, and Major Competitors

Table 63. Upsher-Smith Laboratories, Inc. Major Business

Table 64. Upsher-Smith Laboratories, Inc. C-X-C Chemokine Receptor Type 4 Product and Solutions

Table 65. Upsher-Smith Laboratories, Inc. C-X-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. X4 Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors

Table 67. X4 Pharmaceuticals, Inc. Major Business

Table 68. X4 Pharmaceuticals, Inc. C-X-C Chemokine Receptor Type 4 Product and Solutions

Table 69. X4 Pharmaceuticals, Inc. C-X-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Global C-X-C Chemokine Receptor Type 4 Revenue (USD Million) by Players (2019-2021)

Table 71. Global C-X-C Chemokine Receptor Type 4 Revenue Share by Players (2019-2021)

Table 72. Breakdown of C-X-C Chemokine Receptor Type 4 by Company Type (Tier 1, Tier 2 and Tier 3)

Table 73. C-X-C Chemokine Receptor Type 4 Players Head Office, Products and Services Provided

Table 74. C-X-C Chemokine Receptor Type 4 Mergers & Acquisitions in the Past Five Years

Table 75. C-X-C Chemokine Receptor Type 4 New Entrants and Expansion Plans

Table 76. Global C-X-C Chemokine Receptor Type 4 Revenue (USD Million) by Type (2016-2021)

Table 77. Global C-X-C Chemokine Receptor Type 4 Revenue Share by Type (2016-2021)

Table 78. Global C-X-C Chemokine Receptor Type 4 Revenue Forecast by Type (2021-2026)

Table 79. Global C-X-C Chemokine Receptor Type 4 Revenue by Application (2016-2021)

Table 80. Global C-X-C Chemokine Receptor Type 4 Revenue Forecast by Application (2021-2026)

Table 81. North America C-X-C Chemokine Receptor Type 4 Revenue by Type (2016-2021) & (USD Million)

Table 82. North America C-X-C Chemokine Receptor Type 4 Revenue by Type (2021-2026) & (USD Million)

Table 83. North America C-X-C Chemokine Receptor Type 4 Revenue by Application (2016-2021) & (USD Million)

Table 84. North America C-X-C Chemokine Receptor Type 4 Revenue by Application (2021-2026) & (USD Million)

Table 85. North America C-X-C Chemokine Receptor Type 4 Revenue by Country (2016-2021) & (USD Million)

Table 86. North America C-X-C Chemokine Receptor Type 4 Revenue by Country (2021-2026) & (USD Million)

Table 87. Europe C-X-C Chemokine Receptor Type 4 Revenue by Type (2016-2021) & (USD Million)

Table 88. Europe C-X-C Chemokine Receptor Type 4 Revenue by Type (2021-2026) & (USD Million)

Table 89. Europe C-X-C Chemokine Receptor Type 4 Revenue by Application (2016-2021) & (USD Million)

Table 90. Europe C-X-C Chemokine Receptor Type 4 Revenue by Application (2021-2026) & (USD Million)

Table 91. Europe C-X-C Chemokine Receptor Type 4 Revenue by Country (2016-2021) & (USD Million)

Table 92. Europe C-X-C Chemokine Receptor Type 4 Revenue by Country (2021-2026) & (USD Million)

Table 93. Asia-Pacific C-X-C Chemokine Receptor Type 4 Revenue by Type (2016-2021) & (USD Million)

Table 94. Asia-Pacific C-X-C Chemokine Receptor Type 4 Revenue by Type (2021-2026) & (USD Million)

Table 95. Asia-Pacific C-X-C Chemokine Receptor Type 4 Revenue by Application (2016-2021) & (USD Million)

Table 96. Asia-Pacific C-X-C Chemokine Receptor Type 4 Revenue by Application (2021-2026) & (USD Million)

Table 97. Asia-Pacific C-X-C Chemokine Receptor Type 4 Revenue by Region (2016-2021) & (USD Million)

Table 98. Asia-Pacific C-X-C Chemokine Receptor Type 4 Revenue by Region (2021-2026) & (USD Million)

Table 99. South America C-X-C Chemokine Receptor Type 4 Revenue by Type (2016-2021) & (USD Million)

Table 100. South America C-X-C Chemokine Receptor Type 4 Revenue by Type (2021-2026) & (USD Million)

Table 101. South America C-X-C Chemokine Receptor Type 4 Revenue by Application (2016-2021) & (USD Million)

Table 102. South America C-X-C Chemokine Receptor Type 4 Revenue by Application (2021-2026) & (USD Million)

Table 103. South America C-X-C Chemokine Receptor Type 4 Revenue by Country (2016-2021) & (USD Million)

Table 104. South America C-X-C Chemokine Receptor Type 4 Revenue by Country (2021-2026) & (USD Million)

Table 105. Middle East & Africa C-X-C Chemokine Receptor Type 4 Revenue by Type (2016-2021) & (USD Million)

Table 106. Middle East & Africa C-X-C Chemokine Receptor Type 4 Revenue by Type (2021-2026) & (USD Million)

Table 107. Middle East & Africa C-X-C Chemokine Receptor Type 4 Revenue by Application (2016-2021) & (USD Million)

Table 108. Middle East & Africa C-X-C Chemokine Receptor Type 4 Revenue by Application (2021-2026) & (USD Million)

Table 109. Middle East & Africa C-X-C Chemokine Receptor Type 4 Revenue by Country (2016-2021) & (USD Million)

Table 110. Middle East & Africa C-X-C Chemokine Receptor Type 4 Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. C-X-C Chemokine Receptor Type 4 Picture

Figure 2. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Type in 2020

Figure 3. AM-3114

Figure 4. BL-8040

Figure 5. GMI-1359

Figure 6. HPH-112

Figure 7. Others

Figure 8. C-X-C Chemokine Receptor Type 4 Revenue Market Share by Application in 2020

Figure 9. Liver Cancer Picture

Figure 10. Myocardial Infarction Picture

Figure 11. Renal Cell Carcinoma Picture

Figure 12. Stroke Picture

Figure 13. Others Picture

Figure 14. Global C-X-C Chemokine Receptor Type 4 Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 15. Global C-X-C Chemokine Receptor Type 4 Revenue and Forecast (2016-2026) & (USD Million)

Figure 16. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Region (2016-2026)

Figure 17. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Region in 2020

Figure 18. North America C-X-C Chemokine Receptor Type 4 Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Europe C-X-C Chemokine Receptor Type 4 Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Asia-Pacific C-X-C Chemokine Receptor Type 4 Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. South America C-X-C Chemokine Receptor Type 4 Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Middle East and Africa C-X-C Chemokine Receptor Type 4 Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. C-X-C Chemokine Receptor Type 4 Market Drivers

Figure 24. C-X-C Chemokine Receptor Type 4 Market Restraints

Figure 25. C-X-C Chemokine Receptor Type 4 Market Trends

Figure 26. AdAlta Pty Ltd. Recent Developments and Future Plans

Figure 27. Ambrx, Inc. Recent Developments and Future Plans

Figure 28. Anchor Therapeutics, Inc. Recent Developments and Future Plans

Figure 29. Biokine Therapeutics Ltd. Recent Developments and Future Plans

Figure 30. BioLineRx, Ltd. Recent Developments and Future Plans

Figure 31. Bristol-Myers Squibb Company Recent Developments and Future Plans

Figure 32. Eli Lilly and Company Recent Developments and Future Plans

Figure 33. Globavir Biosciences, Inc. Recent Developments and Future Plans

Figure 34. GlycoMimetics, Inc. Recent Developments and Future Plans

Figure 35. NeED Pharma s.r.l. Recent Developments and Future Plans

Figure 36. Pharis Biotec GmbH Recent Developments and Future Plans

Figure 37. Polyphor Ltd. Recent Developments and Future Plans

Figure 38. Sanofi Recent Developments and Future Plans

Figure 39. TaiGen Biotechnology Co., Ltd. Recent Developments and Future Plans

Figure 40. Upsher-Smith Laboratories, Inc. Recent Developments and Future Plans

Figure 41. X4 Pharmaceuticals, Inc. Recent Developments and Future Plans

Figure 42. Global C-X-C Chemokine Receptor Type 4 Revenue Share by Players in 2020

Figure 43. C-X-C Chemokine Receptor Type 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 44. Global Top 3 Players C-X-C Chemokine Receptor Type 4 Revenue Market Share in 2020

Figure 45. Global Top 10 Players C-X-C Chemokine Receptor Type 4 Revenue Market Share in 2020

Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 47. Global C-X-C Chemokine Receptor Type 4 Revenue Share by Type in 2020

Figure 48. Global C-X-C Chemokine Receptor Type 4 Market Share Forecast by Type (2021-2026)

Figure 49. Global C-X-C Chemokine Receptor Type 4 Revenue Share by Application in 2020

Figure 50. Global C-X-C Chemokine Receptor Type 4 Market Share Forecast by Application (2021-2026)

Figure 51. North America C-X-C Chemokine Receptor Type 4 Sales Market Share by Type (2016-2026)

Figure 52. North America C-X-C Chemokine Receptor Type 4 Sales Market Share by Application (2016-2026)

Figure 53. North America C-X-C Chemokine Receptor Type 4 Revenue Market Share by Country (2016-2026)

Figure 54. United States C-X-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Canada C-X-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Mexico C-X-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Europe C-X-C Chemokine Receptor Type 4 Sales Market Share by Type (2016-2026)

Figure 58. Europe C-X-C Chemokine Receptor Type 4 Sales Market Share by Application (2016-2026)

Figure 59. Europe C-X-C Chemokine Receptor Type 4 Revenue Market Share by Country (2016-2026)

Figure 60. Germany C-X-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. France C-X-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. United Kingdom C-X-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Russia C-X-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Italy C-X-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Asia-Pacific C-X-C Chemokine Receptor Type 4 Sales Market Share by Type (2016-2026)

Figure 66. Asia-Pacific C-X-C Chemokine Receptor Type 4 Sales Market Share by Application (2016-2026)

Figure 67. Asia-Pacific C-X-C Chemokine Receptor Type 4 Revenue Market Share by Region (2016-2026)

Figure 68. China C-X-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Japan C-X-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. South Korea C-X-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. India C-X-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Southeast Asia C-X-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Australia C-X-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. South America C-X-C Chemokine Receptor Type 4 Sales Market Share by Type (2016-2026)

Figure 75. South America C-X-C Chemokine Receptor Type 4 Sales Market Share by Application (2016-2026)

Figure 76. South America C-X-C Chemokine Receptor Type 4 Revenue Market Share by Country (2016-2026)

Figure 77. Brazil C-X-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Argentina C-X-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Middle East and Africa C-X-C Chemokine Receptor Type 4 Sales Market Share by Type (2016-2026)

Figure 80. Middle East and Africa C-X-C Chemokine Receptor Type 4 Sales Market Share by Application (2016-2026)

Figure 81. Middle East and Africa C-X-C Chemokine Receptor Type 4 Revenue Market Share by Country (2016-2026)

Figure 82. Turkey C-X-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. Saudi Arabia C-X-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. UAE C-X-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 85. Methodology

Figure 86. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz